Unlock instant, AI-driven research and patent intelligence for your innovation.
Medicinal composition used for treating hypertension and hyperlipidemia
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A composition and a technology for hyperlipidemia, applied in the field of medicine, can solve problems such as no hypolipidemic effect, and achieve the effects of less adverse reactions, normal activity, and improvement of blood lipids
Inactive Publication Date: 2015-07-01
扬州国纬生物科技有限公司
View PDF1 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Clinically, it is mainly used for the treatment of diseases such as hypertension, ischemic heartdisease and chronic congestive heart failure, but has no effect of lowering blood lipids
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0061] According to methods known in the art to prepare composition tablets, each tablet contains the following ingredients:
[0062] compound composition tablet
[0063] Enalapril maleate 10mg, eucommia extract 40mg, psyllium seed extract 20mg, and the rest of the pharmaceutical excipients are commonly used excipients for tablet preparation.
[0064] Note: The weight of enalapril maleate is calculated by enalapril.
[0065] Preparation process: Prepared according to the conventional preparation process of photographic agent.
Embodiment 2
[0067] According to methods known in the art to prepare composition tablets, each tablet contains the following ingredients:
[0068] compound composition tablet
[0069] Enalapril maleate 5 mg, eucommia extract 20 mg, psyllium seed extract 10 mg, and the rest of the pharmaceutical excipients are commonly used excipients for tablet preparation.
[0070] Note: The weight of enalapril maleate is calculated by enalapril.
[0071] Preparation process: Prepared according to the conventional preparation process of photographic agent.
Embodiment 3
[0073] According to methods known in the art to prepare composition tablets, each tablet contains the following ingredients:
[0074] compound composition tablet
[0075] Enalapril maleate 5 mg, eucommia extract 10 mg, psyllium seed extract 20 mg, and the rest of the pharmaceutical excipients are commonly used excipients for tablet preparation.
[0076] Note: The weight of enalapril maleate is calculated by enalapril.
[0077] Preparation process: Prepared according to the conventional preparation process of photographic agent.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention relates to a medicinal composition used for treating hypertension and hyperlipidemia. The medicinal composition used for treating the hypertension and hyperlipidemia is composed of enalapril or pharmaceutical salt thereof, bark of eucommia and plantain seed extract in a weight ratio of 1:(0.1-100):(0.1-100) and can be prepared into tablets, capsules, granules and the like. Pharmacological study on the medicinal composition used for treating the hypertension and hyperlipidemia shows that the medicinal composition has an ideal effect when being used for treating primary hypertension and hyperlipidemia, can obviously lower blood pressure of a rat and can obviously improve blood lipid level, and an unexpected technical effect is obtained.
Description
technical field [0001] The invention relates to a composition composed of enalapril or its pharmaceutically acceptable salt, Eucommia ulmoides and plantago seed extracts, and the application of this composition in the preparation of medicines for treating hypertension combined with hyperlipidemia, which belongs to the field of medical technology . Background technique [0002] my country is a big country with high blood pressure. According to statistics, one out of every five adults is a hypertensive patient. With the change of people's lifestyle in our country, this trend is still increasing. [0003] A large European evidence-based medical study (ASCOT study) showed that for hypertensive patients, even if the cholesterol level is not high, they can also benefit from lipid-lowering treatment. Hypertensive patients taking lipid-lowering drugs every day on the basis of lowering blood pressure can further reduce the risk of coronary heart disease by 36% and the risk of stroke...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More 
Login to View More 
